ANVS Annovis Bio
- 6.110
- +0.540+9.69%
- 6.280
- +0.170+2.78%
Annovis Bio News
Express News | Annovis Bio Inc - Board Appointed Maria Maccecchini, as the Interim Principal Financial Officer,
Express News | Annovis Bio- Effective April 30, Henry Hagopian Is No Longer Serving as the Chief Financial Officer and as Principal Financial Officer
Express News | Annovis Bio Inc : Maxim Group Cuts to Hold From Buy
BKKT, CETX and SWVL Among Mid-day Movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersAkili (NASDAQ:AKLI) stock moved upwards by 70.1% to $0.4 during Tuesday's regular session. The company's market cap stands at $31.4 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock rose 51
Annovis Bio, Cyclacel Pharmaceuticals, Biodexa Pharmaceuticals Among Healthcare Movers
Annovis Bio Is Maintained at Buy by Canaccord Genuity
Annovis Bio Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Annovis Bio, Lowers Price Target to $26
Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)
Express News | HC Wainwright & Co. Reiterates Buy on Annovis Bio, Maintains $30 Price Target
Annovis Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 320.76% HC Wainwright & Co. → $30 Reiterates Buy → Buy 04/02/2024 320.76% HC Wainwright & Co. $
Top Midday Decliners
Clever Leaves (CLVR) shares slumped nearly 61% in recent trading Monday. The company disclosed Friday its board decided to delist its securities on Nasdaq. ,Intraday trading volume was over 701,000 ve
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday.The Dow traded up 0.19% to 38,313.56 while the NASDAQ rose 0.13% to 15,948.81. The S&P 500
Trending Stocks Today: Collective Audience Shoots up 80.76%
April 29th - US stocks trending in regular trading hours.Gainers: $Collective Audience(CAUD.US)$ soars 80.76% to $0.71 with a turnover of $102.48 million. $Deciphera Pharmaceuticals(DCPH.US)$ shoots u
Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?
Annovis Bio Inc (NASDAQ:ANVS) shares plunged after the company released data from its Phase 2/3 Alzheimer study of buntanetap in mild to moderate Alzheimer's patients. Investors are reacting as during
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
FLGC, BTOG and CAUD Among Mid-day Movers
Annovis Bio Shares Sink After Buntanetap Study Misses Endpoint
By Dean Seal Shares of Annovis Bio plummeted after the phase 2/3 study of its drug candidate buntanetap as a treatment for Alzheimer's disease missed a primary endpoint. The stock was down 59% at $7
Express News | Annovis Bio Shares Resume Trading, Last Down 45.6%
Express News | Annovis Bio Shares Are Trading Lower After the Company Announced Data From Its Phase II/III Alzheimer Study of Buntanetap in Mild to Moderate Alzheimer's. Efficacy in the CGIC Endpoint Was Not Reached Due to the Limited Number of Patients and Short Trial
Analysis
Price Target
No Data
